Johnson Health Tech Co. Ltd.(TW:1736)
NT$109.00-3.50 (-3.11%)
TW:1736
Johnson Health Tech Co. Ltd. financials statements
NT$109.00
At close:-3.50 (-3.11%)
Johnson Health Tech Co. Ltd. (1736) Ratios
Johnson Health Tech Co. Ltd. Ratios
TW:1736's free cash flow for Q2 2026 was NT$2.88B. For the 2026 fiscal year, TW:1736's free cash flow was decreased by NT$-298.71M and operating cash flow was NT$3.18B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.37 | 1.46 | 1.30 | 1.07 | 1.11 |
| Quick Ratio | 0.87 | 0.89 | 0.80 | 0.59 | 0.56 |
| Cash Ratio | 0.13 | 0.13 | 0.13 | 0.14 | 0.12 |
| Solvency Ratio | 0.12 | 0.13 | 0.08 | 0.05 | 0.04 |
| Operating Cash Flow Ratio | 0.10 | 0.05 | 0.21 | 0.02 | -0.17 |
| Short-Term Operating Cash Flow Coverage | 0.28 | 0.14 | 0.49 | 0.03 | -0.29 |
| Net Current Asset Value | NT$ -1.87B | NT$ -1.26B | NT$ -3.16B | NT$ -2.96B | NT$ -2.42B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.40 | 0.45 | 0.49 | 0.47 |
| Debt-to-Equity Ratio | 1.41 | 1.46 | 1.70 | 2.00 | 1.94 |
| Debt-to-Capital Ratio | 0.59 | 0.59 | 0.63 | 0.67 | 0.66 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.38 | 0.38 | 0.21 | 0.27 |
| Financial Leverage Ratio | 3.65 | 3.62 | 3.78 | 4.10 | 4.16 |
| Debt Service Coverage Ratio | 0.42 | 0.56 | 0.30 | 0.11 | 0.11 |
| Interest Coverage Ratio | 9.44 | 9.68 | 3.29 | 2.26 | 4.35 |
| Debt to Market Cap | 0.35 | 0.26 | 0.66 | 0.81 | 0.89 |
| Interest Debt Per Share | 65.24 | 59.20 | 55.39 | 63.36 | 54.83 |
| Net Debt to EBITDA | 3.08 | 2.78 | 4.52 | 8.71 | 10.10 |
| Profitability Margins | |||||
| Gross Profit Margin | 50.56% | 50.81% | 45.36% | 43.45% | 45.18% |
| EBIT Margin | 6.61% | 8.04% | 4.50% | 1.67% | 1.06% |
| EBITDA Margin | 9.63% | 11.22% | 8.17% | 5.26% | 4.44% |
| Operating Profit Margin | 6.61% | 7.08% | 3.26% | 1.72% | 2.31% |
| Pretax Profit Margin | 7.23% | 7.31% | 3.51% | 0.90% | 0.53% |
| Net Profit Margin | 5.06% | 5.09% | 1.86% | 0.67% | 0.32% |
| Continuous Operations Profit Margin | 5.06% | 5.09% | 1.86% | 0.67% | 0.32% |
| Net Income Per EBT | 69.98% | 69.59% | 53.19% | 74.09% | 60.70% |
| EBT Per EBIT | 109.42% | 103.18% | 107.42% | 52.51% | 23.01% |
| Return on Assets (ROA) | 5.49% | 5.57% | 1.95% | 0.58% | 0.28% |
| Return on Equity (ROE) | 20.03% | 20.19% | 7.36% | 2.37% | 1.17% |
| Return on Capital Employed (ROCE) | 14.40% | 14.83% | 6.79% | 4.11% | 5.01% |
| Return on Invested Capital (ROIC) | 7.18% | 7.62% | 2.46% | 1.46% | 1.62% |
| Return on Tangible Assets | 5.80% | 5.96% | 2.11% | 0.62% | 0.31% |
| Earnings Yield | 6.00% | 4.35% | 3.42% | 1.07% | 0.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.29 | 3.51 | 3.45 | 3.37 | 3.77 |
| Payables Turnover | 3.99 | 4.09 | 5.09 | 4.43 | 4.04 |
| Inventory Turnover | 2.11 | 1.99 | 2.30 | 1.61 | 1.45 |
| Fixed Asset Turnover | 5.50 | 6.13 | 5.11 | 5.01 | 5.35 |
| Asset Turnover | 1.08 | 1.10 | 1.05 | 0.86 | 0.87 |
| Working Capital Turnover Ratio | 5.76 | 6.37 | 10.72 | 16.77 | 9.95 |
| Cash Conversion Cycle | 192.52 | 197.91 | 192.58 | 252.84 | 258.90 |
| Days of Sales Outstanding | 110.98 | 103.97 | 105.70 | 108.47 | 96.75 |
| Days of Inventory Outstanding | 172.97 | 183.22 | 158.62 | 226.77 | 252.54 |
| Days of Payables Outstanding | 91.43 | 89.29 | 71.74 | 82.40 | 90.39 |
| Operating Cycle | 283.95 | 287.20 | 264.32 | 335.24 | 349.29 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.49 | 3.48 | 12.68 | 1.30 | -11.69 |
| Free Cash Flow Per Share | 2.63 | 1.08 | 10.35 | -0.16 | -14.20 |
| Dividend Paid and CapEx Coverage Ratio | 0.86 | 1.02 | 4.62 | 0.66 | -3.22 |
| Capital Expenditure Coverage Ratio | 1.45 | 1.45 | 5.91 | 0.89 | -4.65 |
| Operating Cash Flow Coverage Ratio | 0.13 | 0.06 | 0.23 | 0.02 | -0.22 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.02 | 0.10 | 0.01 | -0.11 |
| Free Cash Flow Yield | 1.74% | 0.58% | 15.09% | -0.23% | -25.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.67 | 22.95 | 29.32 | 93.92 | 170.61 |
| Price-to-Sales (P/S) Ratio | 0.84 | 1.17 | 0.55 | 0.63 | 0.55 |
| Price-to-Book (P/B) Ratio | 3.34 | 4.65 | 2.16 | 2.22 | 2.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 57.42 | 171.14 | 6.63 | -434.56 | -3.96 |
| Price-to-Operating Cash Flow Ratio | 17.79 | 53.08 | 5.41 | 53.59 | -4.82 |
| Price-to-Earnings Growth (PEG) Ratio | 1.31 | 0.09 | 0.14 | 0.76 | -2.00 |
| Enterprise Value Multiple | 11.84 | 13.21 | 11.20 | 20.62 | 22.56 |
| Enterprise Value | 61.95B | 70.83B | 34.84B | 36.42B | 30.85B |
| EV to EBITDA | 11.84 | 13.21 | 11.20 | 20.62 | 22.56 |
| EV to Sales | 1.14 | 1.48 | 0.92 | 1.08 | 1.00 |
| EV to Free Cash Flow | 77.61 | 216.75 | 11.11 | -752.45 | -7.18 |
| EV to Operating Cash Flow | 24.04 | 67.23 | 9.07 | 92.80 | -8.72 |
| Tangible Book Value Per Share | 36.24 | 30.41 | 22.54 | 21.89 | 21.73 |
| Shareholders’ Equity Per Share | 45.23 | 39.71 | 31.83 | 31.31 | 28.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.30 | 0.30 | 0.47 | 0.26 | 0.39 |
| Revenue Per Share | 178.98 | 157.65 | 125.67 | 111.07 | 101.72 |
| Net Income Per Share | 9.06 | 8.02 | 2.34 | 0.74 | 0.33 |
| Tax Burden | 0.70 | 0.70 | 0.53 | 0.74 | 0.61 |
| Interest Burden | 1.09 | 0.91 | 0.78 | 0.54 | 0.50 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 |
| SG&A to Revenue | 0.42 | 0.41 | 0.42 | 0.41 | 0.41 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.66 | 0.30 | 5.41 | 1.29 | -21.61 |
Currency in TWD
